Breast Cancer Patient Flap Management After Mastectomy: A Best Practice Implementation Project.

IF 2.9 3区 医学 Q2 ONCOLOGY
Minshan Liang, Yuanzhen Luo, Xiaojun Wang, Chunhua Chen, Piao Chen, Zhenchong Xiong, Li Liu, Mengxiao Jiang, Huiting Zhang
{"title":"Breast Cancer Patient Flap Management After Mastectomy: A Best Practice Implementation Project.","authors":"Minshan Liang, Yuanzhen Luo, Xiaojun Wang, Chunhua Chen, Piao Chen, Zhenchong Xiong, Li Liu, Mengxiao Jiang, Huiting Zhang","doi":"10.1016/j.clbc.2024.09.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is a prevalent malignancy in women, with mastectomy as the main surgery. Common postmastectomy complications are seroma (15%-81%), infections (2.9%-3.8%), and flap necrosis (10%-18%), severely impacting quality of life and costs. However, there's a lack of standardized flap care protocols and limited staff knowledge.</p><p><strong>Objectives: </strong>This study aims to apply best evidence for flap management post-mastectomy to standardize practices, reduce complications, and enhance patient's quality of life.</p><p><strong>Methods: </strong>This project followed JBI PACES and GRiP principles, implementing evidence-based practices in a Chinese tertiary hospital between January and May 2023. It entailed evidence identification, integration into clinical context, protocol development, baseline audits, barrier/enabler analysis. The study compared pre- and post-evidence implementation rates of flap complications, healthcare staff's knowledge/skill scores on mastectomy flap management, and audit indicator adherence by both staff and patients.</p><p><strong>Results: </strong>After evidence application, flap ischemia/necrosis rates dropped from 8.57% to 5.56% (P < .001), wound infection rates after surgery reduced from 5.71% to 2.78% (P < .001), and seroma rates decreased from 17.14% to 2.78% (P < .001). Healthcare staff's knowledge and skill scores for flap management following mastectomy increased from 50.67 ±18.32 preimplementation to 98.33 ± 4.01 (t = -13.90, P < .001). Audit criterion compliance rates increased from 8.57% to 94.29% to between 91.67% and 100%, with statistically significant differences in all 15 criteria (P < .001).</p><p><strong>Conclusions: </strong>Evidence-based management of flaps after mastectomy improves healthcare staff's knowledge and skills, enhances nursing quality, effectively reduces flap complications in patients, and boosts their quality of life.</p>","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clbc.2024.09.004","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Breast cancer is a prevalent malignancy in women, with mastectomy as the main surgery. Common postmastectomy complications are seroma (15%-81%), infections (2.9%-3.8%), and flap necrosis (10%-18%), severely impacting quality of life and costs. However, there's a lack of standardized flap care protocols and limited staff knowledge.

Objectives: This study aims to apply best evidence for flap management post-mastectomy to standardize practices, reduce complications, and enhance patient's quality of life.

Methods: This project followed JBI PACES and GRiP principles, implementing evidence-based practices in a Chinese tertiary hospital between January and May 2023. It entailed evidence identification, integration into clinical context, protocol development, baseline audits, barrier/enabler analysis. The study compared pre- and post-evidence implementation rates of flap complications, healthcare staff's knowledge/skill scores on mastectomy flap management, and audit indicator adherence by both staff and patients.

Results: After evidence application, flap ischemia/necrosis rates dropped from 8.57% to 5.56% (P < .001), wound infection rates after surgery reduced from 5.71% to 2.78% (P < .001), and seroma rates decreased from 17.14% to 2.78% (P < .001). Healthcare staff's knowledge and skill scores for flap management following mastectomy increased from 50.67 ±18.32 preimplementation to 98.33 ± 4.01 (t = -13.90, P < .001). Audit criterion compliance rates increased from 8.57% to 94.29% to between 91.67% and 100%, with statistically significant differences in all 15 criteria (P < .001).

Conclusions: Evidence-based management of flaps after mastectomy improves healthcare staff's knowledge and skills, enhances nursing quality, effectively reduces flap complications in patients, and boosts their quality of life.

乳腺癌患者乳房切除术后的皮瓣管理:最佳实践实施项目。
背景:乳腺癌是女性的常见恶性肿瘤,主要手术是乳房切除术。常见的乳房切除术后并发症有血清肿(15%-81%)、感染(2.9%-3.8%)和皮瓣坏死(10%-18%),严重影响生活质量和费用。然而,目前缺乏标准化的皮瓣护理方案,工作人员的知识也有限:本研究旨在应用最佳证据进行乳房切除术后皮瓣管理,以规范操作、减少并发症并提高患者的生活质量:该项目遵循 JBI PACES 和 GRiP 原则,于 2023 年 1 月至 5 月在一家中国三级医院实施循证实践。项目包括证据识别、临床整合、方案制定、基线审计、障碍/促进因素分析。研究比较了实施前和实施后的皮瓣并发症发生率、医护人员对乳房切除皮瓣管理的知识/技能评分,以及医护人员和患者对审计指标的遵守情况:应用证据后,皮瓣缺血/坏死率从 8.57% 降至 5.56% (P < .001),术后伤口感染率从 5.71% 降至 2.78% (P < .001),血清肿发生率从 17.14% 降至 2.78% (P < .001)。医护人员对乳房切除术后皮瓣管理的知识和技能评分从实施前的 50.67 ± 18.32 增加到 98.33 ± 4.01(t = -13.90,P < .001)。审计标准符合率从 8.57% 到 94.29% 增加到 91.67% 到 100%,所有 15 项标准的符合率差异均有统计学意义(P < .001):乳房切除术后皮瓣的循证管理提高了医护人员的知识和技能,提升了护理质量,有效减少了患者的皮瓣并发症,提高了患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical breast cancer
Clinical breast cancer 医学-肿瘤学
CiteScore
5.40
自引率
3.20%
发文量
174
审稿时长
48 days
期刊介绍: Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信